Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
78.65
Dollar change
+0.66
Percentage change
0.85
%
IndexRUT P/E- EPS (ttm)-2.41 Insider Own48.20% Shs Outstand58.63M Perf Week7.93%
Market Cap5.08B Forward P/E- EPS next Y-3.66 Insider Trans-3.98% Shs Float33.44M Perf Month-0.51%
Income-145.51M PEG- EPS next Q-0.76 Inst Own61.43% Short Float21.63% Perf Quarter15.66%
Sales0.00M P/S- EPS this Y-41.77% Inst Trans-1.03% Short Ratio17.23 Perf Half Y6.08%
Book/sh10.47 P/B7.51 EPS next Y-18.91% ROA-24.88% Short Interest7.23M Perf Year85.71%
Cash/sh10.72 P/C7.34 EPS next 5Y- ROE-26.01% 52W Range39.86 - 89.39 Perf YTD6.88%
Dividend Est.- P/FCF- EPS past 5Y-72.54% ROI-21.56% 52W High-12.01% Beta1.27
Dividend TTM- Quick Ratio20.93 Sales past 5Y0.00% Gross Margin- 52W Low97.32% ATR (14)2.98
Dividend Ex-Date- Current Ratio20.93 EPS Y/Y TTM-40.04% Oper. Margin0.00% RSI (14)59.65 Volatility4.11% 3.52%
Employees92 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.10 Target Price101.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-56.07% Payout- Rel Volume0.61 Prev Close77.99
Sales Surprise- EPS Surprise-4.15% Sales Q/Q- EarningsMay 09 BMO Avg Volume419.83K Price78.65
SMA202.53% SMA507.82% SMA20011.96% Trades Volume257,554 Change0.85%
Date Action Analyst Rating Change Price Target Change
Apr-17-24Initiated Jefferies Buy $97
Apr-01-24Upgrade Leerink Partners Market Perform → Outperform $69 → $110
Feb-28-24Resumed Guggenheim Buy $99
Feb-23-24Initiated Robert W. Baird Outperform $105
Sep-27-23Initiated Stifel Buy $65
Aug-08-23Initiated SVB Securities Market Perform $42
Jul-24-23Initiated Guggenheim Buy $56
Jan-18-23Initiated Wedbush Outperform $39
Jun-24-22Initiated BMO Capital Markets Outperform $28
Jul-11-24 06:30AM
Jun-24-24 06:00AM
May-29-24 06:30AM
May-17-24 04:48PM
06:31AM
04:23PM Loading…
May-16-24 04:23PM
04:01PM
May-09-24 01:56PM
09:27AM
07:19AM
06:30AM
May-08-24 05:22PM
10:21AM
May-01-24 05:05PM
Apr-08-24 04:30PM
07:00PM Loading…
Apr-05-24 07:00PM
06:30PM
Mar-29-24 07:01PM
Mar-25-24 07:01PM
Mar-19-24 07:01PM
Mar-05-24 04:52PM
Feb-29-24 04:32AM
Feb-27-24 06:30AM
06:15AM
Feb-22-24 04:00AM
Feb-12-24 06:30AM
Feb-01-24 06:30AM
Jan-08-24 06:30AM
Dec-22-23 03:01PM
Dec-21-23 01:01PM
06:30AM Loading…
06:30AM
Nov-14-23 07:15PM
06:30AM
Nov-04-23 07:02AM
Nov-01-23 06:30AM
Oct-23-23 02:50AM
Oct-17-23 06:27PM
Oct-16-23 09:55PM
07:30AM
Oct-13-23 06:30AM
Oct-07-23 01:00AM
Oct-05-23 07:13PM
10:29AM
01:01AM
Oct-04-23 04:13PM
12:21PM
Sep-18-23 06:30AM
Sep-05-23 06:30AM
Aug-31-23 06:30AM
Aug-17-23 06:40AM
Aug-10-23 06:30AM
Aug-08-23 10:02AM
Aug-01-23 06:30AM
Jul-21-23 08:50AM
Jun-07-23 08:50AM
May-24-23 06:30AM
May-11-23 06:30AM
Apr-19-23 06:30AM
Apr-18-23 09:00AM
Apr-02-23 10:56AM
Mar-23-23 06:30AM
Mar-16-23 06:30AM
Mar-14-23 05:59PM
Mar-01-23 06:30AM
Jan-04-23 06:30AM
Jan-02-23 09:40AM
Dec-13-22 10:15AM
Dec-12-22 03:44PM
Dec-02-22 08:50AM
Nov-17-22 12:00PM
Nov-10-22 06:30AM
Nov-03-22 08:13PM
Oct-31-22 09:14PM
07:15AM
Oct-28-22 04:18PM
04:06PM
11:10AM
12:01AM
Oct-26-22 06:30AM
Oct-23-22 09:26AM
Oct-17-22 06:30AM
Oct-06-22 06:30AM
Sep-20-22 10:16AM
Sep-07-22 06:30AM
Sep-01-22 06:30AM
Aug-10-22 06:30AM
Aug-05-22 06:30AM
Aug-03-22 06:30AM
Jul-20-22 06:30AM
Jul-13-22 06:30AM
Jul-01-22 10:52AM
Jun-21-22 06:30AM
Jun-02-22 06:38AM
May-16-22 09:10AM
May-12-22 06:30AM
Apr-11-22 07:21AM
Apr-08-22 01:15PM
Apr-07-22 06:30AM
Mar-31-22 06:30AM
Mar-29-22 06:30AM
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miller Deborah AnnChief Legal OfficerJul 08 '24Option Exercise6.893,00020,67036,300Jul 10 04:45 PM
Miller Deborah AnnChief Legal OfficerJul 08 '24Sale73.233,000219,68733,300Jul 10 04:45 PM
Noci DarleneChief Development OfficerJul 01 '24Option Exercise18.935,00094,65038,300Jul 02 04:47 PM
Noci DarleneChief Development OfficerJul 01 '24Sale75.545,000377,69633,300Jul 02 04:47 PM
Balcom AlexandraChief Financial OfficerJun 28 '24Option Exercise27.8510,000278,50043,300Jul 02 04:44 PM
Balcom AlexandraChief Financial OfficerJun 28 '24Sale75.4310,000754,34133,300Jul 02 04:44 PM
Shair MatthewDirectorJun 24 '24Sale80.222,000160,438232,522Jun 26 04:54 PM
Conley EmilyDirectorJun 14 '24Option Exercise13.795,00068,9507,507Jun 18 04:15 PM
Conley EmilyDirectorJun 14 '24Sale77.565,000387,7762,507Jun 18 04:15 PM
Miller Deborah AnnChief Legal OfficerJun 06 '24Option Exercise14.418,000115,32041,300Jun 07 04:44 PM
Miller Deborah AnnChief Legal OfficerJun 06 '24Sale80.408,000643,21333,300Jun 07 04:44 PM
Shair MatthewDirectorMay 28 '24Sale67.222,000134,438234,522May 29 04:43 PM
Conley EmilyDirectorMay 15 '24Option Exercise12.315,00061,5655,008May 17 04:41 PM
Conley EmilyDirectorMay 15 '24Sale69.095,000345,4508May 17 04:41 PM
Shair MatthewDirectorMay 13 '24Sale65.8437,5002,468,8661,424,698May 15 04:54 PM
Shair MatthewDirectorMay 06 '24Sale69.4837,5002,605,5251,462,198May 08 04:51 PM
Miller Deborah AnnChief Legal OfficerMay 02 '24Option Exercise6.893,00020,67036,300May 03 04:47 PM
Miller Deborah AnnChief Legal OfficerMay 02 '24Sale72.073,000216,20333,300May 03 04:47 PM
Shair MatthewDirectorApr 29 '24Sale67.5137,5002,531,5371,499,698May 01 04:41 PM
Shair MatthewDirectorApr 29 '24Sale67.512,000135,018236,522May 01 04:41 PM
Shair MatthewDirectorApr 22 '24Sale63.6537,5002,386,9101,537,198Apr 24 04:44 PM
Conley EmilyDirectorApr 15 '24Option Exercise9.365,00046,8005,008Apr 17 04:44 PM
Shair MatthewDirectorApr 15 '24Sale65.5637,5002,458,3351,574,698Apr 17 04:46 PM
Conley EmilyDirectorApr 15 '24Sale65.525,000327,6078Apr 17 04:44 PM
Shair MatthewDirectorApr 08 '24Sale68.4437,5002,566,4791,612,198Apr 10 04:45 PM
Miller Deborah AnnChief Legal OfficerApr 04 '24Option Exercise6.893,00020,67036,300Apr 05 04:47 PM
Miller Deborah AnnChief Legal OfficerApr 04 '24Sale73.603,000220,78733,300Apr 05 04:47 PM
Shair MatthewDirectorApr 01 '24Sale76.9237,5002,884,3371,649,698Apr 03 04:45 PM
Miller Deborah AnnChief Legal OfficerMar 28 '24Option Exercise22.5822,000496,74055,300Mar 29 04:46 PM
Miller Deborah AnnChief Legal OfficerMar 28 '24Sale75.2022,0001,654,31133,300Mar 29 04:46 PM
Hack Andrew A. F.DirectorMar 27 '24Sale72.77880,00064,035,9592,697,267Mar 29 05:15 PM
Shair MatthewDirectorMar 25 '24Sale76.7737,5002,878,9821,687,198Mar 27 04:55 PM
Shair MatthewDirectorMar 25 '24Sale76.772,000153,546238,522Mar 27 04:55 PM
Noci DarleneChief Development OfficerMar 22 '24Option Exercise7.7420,000154,80053,300Mar 25 04:49 PM
Noci DarleneChief Development OfficerMar 22 '24Sale77.5120,0001,550,22933,300Mar 25 04:49 PM
Conley EmilyDirectorMar 15 '24Option Exercise9.3613,333124,79713,341Mar 19 04:46 PM
Conley EmilyDirectorMar 15 '24Sale80.9213,3331,078,8838Mar 19 04:46 PM
Shair MatthewDirectorDec 28 '23Sale75.4648,5483,663,4921,724,698Dec 28 05:09 PM
Shair MatthewDirectorDec 27 '23Sale75.171,00075,1701,773,246Dec 28 05:09 PM
Shair MatthewDirectorDec 26 '23Sale75.1269,6025,228,3461,774,246Dec 28 05:09 PM
Miller Deborah AnnChief Legal OfficerDec 19 '23Option Exercise18.935,00094,6505,000Dec 20 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 19 '23Sale75.005,000375,0000Dec 20 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 18 '23Option Exercise27.8533,046920,33133,046Dec 20 04:54 PM
Noci DarleneChief Development OfficerDec 18 '23Option Exercise4.7040,000188,13940,000Dec 20 04:56 PM
Protopapas AnnaDirectorDec 18 '23Option Exercise9.365,00046,8005,000Dec 20 04:58 PM
Balcom AlexandraChief Financial OfficerDec 18 '23Option Exercise1.0830,00032,40030,000Dec 20 04:51 PM
Noci DarleneChief Development OfficerDec 18 '23Sale75.8240,0003,032,8000Dec 20 04:56 PM
Miller Deborah AnnChief Legal OfficerDec 18 '23Sale75.8233,0462,505,5480Dec 20 04:54 PM
Balcom AlexandraChief Financial OfficerDec 18 '23Sale75.8230,0002,274,6000Dec 20 04:51 PM
Protopapas AnnaDirectorDec 18 '23Sale75.675,000378,3500Dec 20 04:58 PM
Shair MatthewDirectorNov 28 '23Sale61.899,150566,3031,843,848Nov 30 04:47 PM
Noci DarleneChief Development OfficerNov 01 '23Option Exercise1.083,0003,2403,000Nov 03 04:43 PM
Noci DarleneChief Development OfficerNov 01 '23Sale52.663,000157,9750Nov 03 04:43 PM
Shair MatthewDirectorOct 24 '23Sale50.7091,7004,648,8721,852,998Oct 26 04:47 PM
Noci DarleneChief Development OfficerOct 04 '23Option Exercise5.5620,000111,15020,000Oct 06 04:56 PM
Turner Christopher DurantChief Medical OfficerOct 04 '23Option Exercise6.897,99555,08622,508Oct 06 04:58 PM
Noci DarleneChief Development OfficerOct 04 '23Sale55.9920,0001,119,7020Oct 06 04:56 PM
Turner Christopher DurantChief Medical OfficerOct 04 '23Sale54.047,995432,03114,513Oct 06 04:58 PM
Noci DarleneChief Development OfficerOct 02 '23Option Exercise1.083,0003,2403,000Oct 04 04:24 PM
Noci DarleneChief Development OfficerOct 02 '23Sale45.883,000137,6490Oct 04 04:24 PM
Miller Deborah AnnChief Legal OfficerSep 15 '23Option Exercise6.892,00013,7802,000Sep 19 04:45 PM
Miller Deborah AnnChief Legal OfficerSep 15 '23Sale47.642,00095,2830Sep 19 04:45 PM
Noci DarleneChief Development OfficerSep 01 '23Option Exercise1.083,0003,2403,000Sep 06 04:36 PM
Noci DarleneChief Development OfficerSep 01 '23Sale46.563,000139,6920Sep 06 04:36 PM
Miller Deborah AnnChief Legal OfficerAug 15 '23Option Exercise6.892,00013,7802,000Aug 17 04:29 PM
Miller Deborah AnnChief Legal OfficerAug 15 '23Sale42.652,00085,3100Aug 17 04:29 PM
Noci DarleneChief Development OfficerAug 01 '23Option Exercise1.083,0003,2403,000Aug 01 05:26 PM
Noci DarleneChief Development OfficerAug 01 '23Sale49.953,000149,8440Aug 01 05:26 PM
Balcom AlexandraChief Financial OfficerJul 31 '23Option Exercise1.0825,00027,00025,000Aug 01 04:16 PM
Balcom AlexandraChief Financial OfficerJul 31 '23Sale48.9925,0001,224,7960Aug 01 04:16 PM
Miller Deborah AnnChief Legal OfficerJul 28 '23Option Exercise6.896,50044,7856,500Aug 01 04:13 PM
Turner Christopher DurantChief Medical OfficerJul 28 '23Option Exercise6.892,66518,36217,178Jul 28 04:51 PM
Miller Deborah AnnChief Legal OfficerJul 28 '23Sale48.526,500315,3800Aug 01 04:13 PM
Turner Christopher DurantChief Medical OfficerJul 28 '23Sale48.932,665130,39814,513Jul 28 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 26 '23Option Exercise6.892,36516,29516,878Jul 28 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 26 '23Sale46.852,365110,80014,513Jul 28 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 24 '23Option Exercise6.892001,37814,713Jul 24 04:54 PM
Turner Christopher DurantChief Medical OfficerJul 24 '23Sale46.822009,36414,513Jul 24 04:54 PM
Noci DarleneChief Development OfficerJul 20 '23Option Exercise1.0810,94111,81610,941Jul 21 04:47 PM
Turner Christopher DurantChief Medical OfficerJul 20 '23Option Exercise6.8910068914,613Jul 24 04:54 PM
Noci DarleneChief Development OfficerJul 20 '23Sale45.1710,941494,2050Jul 21 04:47 PM
Turner Christopher DurantChief Medical OfficerJul 20 '23Sale46.801004,68014,513Jul 24 04:54 PM
Noci DarleneChief Development OfficerJul 19 '23Option Exercise1.084,5594,9244,559Jul 21 04:47 PM
Noci DarleneChief Development OfficerJul 19 '23Sale45.044,559205,3370Jul 21 04:47 PM
Miller Deborah AnnChief Legal OfficerJul 17 '23Option Exercise6.892,00013,7802,000Jul 19 04:43 PM
Miller Deborah AnnChief Legal OfficerJul 17 '23Sale43.062,00086,1230Jul 19 04:43 PM